Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386696988> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W4386696988 endingPage "152211" @default.
- W4386696988 startingPage "152211" @default.
- W4386696988 abstract "Pathologists face ongoing challenges distinguishing between benign and malignant melanocytic tumors. PRAME (PReferentially expressed Antigen in Melanoma) has a demonstrated value distinguishing between these types of lesions. However, the sensitivity of single immunohistochemistry is variable. HMB-45 is another valuable marker, but on its own, has a limited ability in setting of primary melanocytic tumors. This study sought to evaluate the diagnostic potential of a dual panel combining PRAME and HMB-45 in the assessment of primary melanocytic tumors.259 tumors, of which 141 were benign nevi, 31 dysplastic nevi (either low- or high grade dysplasia), and further 87 malignant melanomas, were retrieved from the department's archives and assessed by two experienced dermatopathologists. New sections were stained with PRAME and HMB-45, respectively. For PRAME, a nuclear, and for HMB-45, a cytoplasmic staining, was considered positive and scored as described in the literature on a scale from 0 to 4+. Only dermal component was assessed on HMB-45 stain.PRAME was diffusely expressed in only 1 benign nevus, with focal expression in further 28 compared to 22 diffusely and 103 focally HMB-45-positive benign nevi. 5 high-grade dysplastic nevi showed diffuse PRAME expression in epidermal component, with varying degree of positivity in adjacent dermal compartment, and further 8 dysplastic nevi showed only focal expression. HMB-45 was diffusely expressed in only 2, with focal expression in 23, and no apparent positivity in remaining 6 dysplastic nevi. In invasive melanoma group, PRAME stained >75 % cells in 64/87 tumors, however, 10/87 melanomas were completely negative. HMB-45 was captured diffusely in 49/87 melanomas, 32 showed patchy expression, and 6 tumors were blank negative. Diffuse 4+ PRAME positivity showed superior sensitivity and specificity of 73,6 % and 96,5 %, respectively, compared to HMB-45, 56,3 % and 86,0 %, respectively. No nevi showed double 4+ positivity, however, the sensitivity for double positivity was only 49,4 %.Our results confirm the superiority of PRAME over HMB-45 in the differential diagnosis of melanocytic tumors. However, combined staining can significantly increase specificity, rendering a benign diagnosis more unlikely in a double 4+ diffuse positivity setting." @default.
- W4386696988 created "2023-09-14" @default.
- W4386696988 creator A5011912106 @default.
- W4386696988 creator A5023856114 @default.
- W4386696988 creator A5065164045 @default.
- W4386696988 creator A5075198498 @default.
- W4386696988 date "2023-12-01" @default.
- W4386696988 modified "2023-09-27" @default.
- W4386696988 title "Diagnostic utility of combining PRAME and HMB-45 stains in primary melanocytic tumors" @default.
- W4386696988 cites W1824377994 @default.
- W4386696988 cites W1972206478 @default.
- W4386696988 cites W1993191461 @default.
- W4386696988 cites W2070192318 @default.
- W4386696988 cites W2082790915 @default.
- W4386696988 cites W2112642558 @default.
- W4386696988 cites W2115052984 @default.
- W4386696988 cites W2164777277 @default.
- W4386696988 cites W2793381003 @default.
- W4386696988 cites W2884769110 @default.
- W4386696988 cites W2995117452 @default.
- W4386696988 cites W3015776079 @default.
- W4386696988 cites W3044342719 @default.
- W4386696988 cites W3100185244 @default.
- W4386696988 cites W3106826169 @default.
- W4386696988 cites W3112210822 @default.
- W4386696988 cites W3120902077 @default.
- W4386696988 cites W3159444276 @default.
- W4386696988 cites W3190693096 @default.
- W4386696988 cites W4281483269 @default.
- W4386696988 cites W4283526062 @default.
- W4386696988 cites W4288063339 @default.
- W4386696988 cites W4295537133 @default.
- W4386696988 cites W4302763047 @default.
- W4386696988 cites W4328048231 @default.
- W4386696988 doi "https://doi.org/10.1016/j.anndiagpath.2023.152211" @default.
- W4386696988 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37717457" @default.
- W4386696988 hasPublicationYear "2023" @default.
- W4386696988 type Work @default.
- W4386696988 citedByCount "0" @default.
- W4386696988 crossrefType "journal-article" @default.
- W4386696988 hasAuthorship W4386696988A5011912106 @default.
- W4386696988 hasAuthorship W4386696988A5023856114 @default.
- W4386696988 hasAuthorship W4386696988A5065164045 @default.
- W4386696988 hasAuthorship W4386696988A5075198498 @default.
- W4386696988 hasBestOaLocation W43866969881 @default.
- W4386696988 hasConcept C142724271 @default.
- W4386696988 hasConcept C16005928 @default.
- W4386696988 hasConcept C200583388 @default.
- W4386696988 hasConcept C204232928 @default.
- W4386696988 hasConcept C2776294769 @default.
- W4386696988 hasConcept C2777377415 @default.
- W4386696988 hasConcept C2777658100 @default.
- W4386696988 hasConcept C2779323059 @default.
- W4386696988 hasConcept C502942594 @default.
- W4386696988 hasConcept C71924100 @default.
- W4386696988 hasConcept C74864618 @default.
- W4386696988 hasConceptScore W4386696988C142724271 @default.
- W4386696988 hasConceptScore W4386696988C16005928 @default.
- W4386696988 hasConceptScore W4386696988C200583388 @default.
- W4386696988 hasConceptScore W4386696988C204232928 @default.
- W4386696988 hasConceptScore W4386696988C2776294769 @default.
- W4386696988 hasConceptScore W4386696988C2777377415 @default.
- W4386696988 hasConceptScore W4386696988C2777658100 @default.
- W4386696988 hasConceptScore W4386696988C2779323059 @default.
- W4386696988 hasConceptScore W4386696988C502942594 @default.
- W4386696988 hasConceptScore W4386696988C71924100 @default.
- W4386696988 hasConceptScore W4386696988C74864618 @default.
- W4386696988 hasLocation W43866969881 @default.
- W4386696988 hasLocation W43866969882 @default.
- W4386696988 hasOpenAccess W4386696988 @default.
- W4386696988 hasPrimaryLocation W43866969881 @default.
- W4386696988 hasRelatedWork W1937473035 @default.
- W4386696988 hasRelatedWork W1988804311 @default.
- W4386696988 hasRelatedWork W2007392520 @default.
- W4386696988 hasRelatedWork W2028466308 @default.
- W4386696988 hasRelatedWork W2062778449 @default.
- W4386696988 hasRelatedWork W2119187831 @default.
- W4386696988 hasRelatedWork W2318294399 @default.
- W4386696988 hasRelatedWork W2403527867 @default.
- W4386696988 hasRelatedWork W2615199802 @default.
- W4386696988 hasRelatedWork W4252912071 @default.
- W4386696988 hasVolume "67" @default.
- W4386696988 isParatext "false" @default.
- W4386696988 isRetracted "false" @default.
- W4386696988 workType "article" @default.